Tumor necrosis factor unresponsiveness after surgery in bile duct-ligated rats

American Journal of Physiology

Volumn 271, Issue 6 PART 1, 1996, Pages

  Houdijk, A P J ^a,b   Boermeester, M A ^a,b   Wesdorp, R I C ^a,b   Erik Hack, C ^a,b   Van Leeuwen, P A M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Medical Research of the Netherlands Organization of Scientific Research

Author keywords

Cytokines; Endotoxin tolerance; Interleukin 6; Obstructive jaundice

Indexed keywords

CD14 ANTIGEN; COLESTYRAMINE; ENDOTOXIN; INTERLEUKIN 6; MONOCLONAL ANTIBODY; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; ENDOTOXEMIA; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; RAT;

ANIMALS; BILE DUCTS; CHOLESTYRAMINE; ENDOTOXINS; INTERLEUKIN-6; MALE; POSTOPERATIVE COMPLICATIONS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030458336     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1996.271.6.g980     Document Type: Article

References (30)

1. Aarden, L. A.,E. R. De Groot, O. L. Schaap, and P. M. Lansdorp. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 17: 1411-1416, 1987.
2. Bemelmans, M. H. A.,D. J. Gouma, J. W. Greve, and W. A. Buurman. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 15: 1132-1136, 1992.
3. Beutler, B.,and A. Cerami. Cachectin: more than a tumor necrosis factor. N. Engl. J. Med. 316: 379-385, 1987.
4. Boermeester, M. A.,A. P. J. Houdijk, S. Meyer, M. A. Cuesta, B. J.,Appelmelk, R. I. C. Wesdorp, C. E. Hack, and P. A. M. Van Leeuwen. Liver failure induces a systemic inflammatory response: prevention by recombinant N-terminal bactericidal/ permeability increasing protein. Am. J. Pathol. 147: 1428-1440, 1995.
5. Brakenhof, J. P. J.,E. R. de Groot, R. F. Evers, H. Pannekoek, and L. A. Aarden. Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J. Immunol. 39: 4116-4121, 1987.
6. Clements, W. D. B.,M. I. Halliday, M. D. McCaigue, R. G. Barclay, and B. J. Rowlands. Effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity. Arch. Surg. 128: 200-205, 1993.
7. Cornell, R. P. Restriction of gut-derived endotoxin impairs DNA synthesis for liver regeneration. Am. J. Physiol. 249 (Regulatory Integrative Comp. Physiol. 18): R563-R569, 1985.
8. Dixon, J. M.,C. P. Armstrong, S. W. Duffy, and G. C. Davies. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 24: 845-852, 1983.
9. Engelhardt, R.,A. Mackenson, and C. Galanos. Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients. Cancer Res. 51: 2524-2530, 1991.
10. Espevik, T.,and J. Nissen-Meyer. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95: 99-105, 1986.
11. Flohé, S.,P. C. Heinrich, J. Schneider, A. Wendel, and L. Flohé. Time course of IL-6 and TNF-́ release during endotoxin-induced endotoxin tolerance in rats. Biochem. Pharmacol. 41: 1607-1614, 1991.
12. Freudenberg, M. A.,and C. Galanos. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect. Immunol. 56: 1352-1357, 1988.
13. Hansen, M. B.,S. E. Nielsen, and K. Berg. Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119: 203-210, 1989.
14. Helle, M.,L. Boeije, and L. A. Aarden. Functional discrimination between interleukin 6 and interleukin 1. Eur. J. Immunol. 18: 1535-1540, 1988.
15. Heremans, H.,J. van Damme, C. Dillen, R. Dijkmans, and A. Billiau. Interferon-γ, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J. Exp. Med. 171: 1853-1869, 1990.
16. Hunt, D. R.,M. E. Allison, C. R. Prentice, and L. H. Blumgart. Endotoxemia, disturbance of coagulation and obstructive jaundice. Am. J. Surg. 144: 325-329, 1982.
17. Ingoldby, C. J.,G. A. D. McPherson, and L. H. Blumgart. Endotoxemia in human obstructive jaundice. Am. J. Surg. 147: 766-771, 1984.
18. Lee, E. The effect of obstructive jaundice on the migration of reticuloendothelial cells and fibroblasts into early experimental granulomata. Br. J. Surg. 59: 875-877, 1972.
19. Van Leeuwen, P. A. M.,R. W. Hong, J. D. Rounds, M. Rodrick, and D. W. Wilmore. Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin. Surgery St. Louis 110: 169-175, 1991.
20. Mackenson, A.,C. Galanos, U. Wehr, and R. Engelhardt. Endotoxin tolerance: regulation of cytokine production and cellular changes in response to endotoxin application in cancer patients. Eur. Cytokine Network 3: 571-579, 1992.
21. Mengozzi, M.,and P. Ghezzi. Cytokine downregulation in endotoxin tolerance. Eur. Cytokine Network 4: 89-98, 1993.
22. Michie, H. R.,K. R. Manoque, D. R. Spriggs, A. Revhaug, S. O'Dwyer, C. A. Dinarello, A. Cerami, S. M. Wolff, and D. W. Wilmore. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318: 1481-1486, 1988.
23. Nolan, J. P.,and A. M. Vilayat. Effect of cholestyramine on endotoxin toxicity and absorption. Dig. Dis. 17: 161-166, 1972.
24. Pain, J. A.,C. J. Cahill, and M. E. Bailey. Perioperative complications in obstructive jaundice: therapeutic considerations. Br. J. Surg. 72: 942-945, 1985.
25. Sanchez-Cantu, L.,H. N. Rode, and N. V. Christou. Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch. Surg. 124: 1432-1436, 1989.
26. Sehgal, P. B. Interleukin-6: a regulator of plasma protein gene expression in hepatic and non-hepatic tissues. Mol. Biol. Med. 7: 117-130, 1990.
27. Shands, J. W.,and P. W. Chun. The dispersion of Gram negative lipopolysaccharide by deoxycholate. J. Biol. Chem. 255: 1221-1226, 1980.
28. 28a.Van Deventer, S. J. H.,H. R. Buller, J. W. ten Cate, L. A. Aarden, C. E. Hack, and A. Sturk. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76: 2520-2526, 1990.
29. Wilkinson, S. P.,H. Moodie, D. Stamatakis, V. V. Kakkar, and R. Williams. Endotoxemia and renal failure in cirrhosis and obstructive jaundice. Er. Med. J. 2: 1415-1418, 1976.
30. Wright, S. D.,R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. CD14, a receptor for complexes of lipopolysaccharide (IPS) and LPS binding protein. Science Wash. DC 249: 1431-1433, 1990.